Executive record

Eric Hyllengren, M.B.A.

Most recent record: Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A. (named as the incoming officer), effective July 13, 2026. See Tenaya Therapeutics, Inc..

1 verified record

2026-06-29 · Transition

Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.

This page lists only verified filing records that name Eric Hyllengren, M.B.A.; it is not a career history. Corrections: the corrections page.